ECONOMIC IMPACT OF TREATING SEVERE HEMOPHILIA A PATIENTS WITH PLASMA-DERIVED FACTOR-VIII/VWF VERSUS RECOMBINANT FACTOR-VIII IN THE UNITED STATES

被引：0
|
作者：
O'Day, K. [1 ]
Runken, M. C. [2 ]
Meyer, K. L. [1 ]
Spears, J. B. [2 ]
机构：
[1] Xcenda LLC, Palm Harbor, FL USA
[2] Grifols Inc, Res Triangle Pk, NC USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY46
引用
收藏
页码：A216 / A217
页数：2
相关论文
共 50 条
  • [31] INVERSIONS OF THE FACTOR-VIII GENE IN SWEDISH PATIENTS WITH SEVERE HEMOPHILIA-A
    LJUNG, R
    SJORIN, E
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 54 (05) : 310 - 313
  • [32] FACTOR-VIII INHIBITORS IN PATIENTS WITH HEMOPHILIA-A - EPIDEMIOLOGY OF INHIBITOR DEVELOPMENT AND INDUCTION OF IMMUNE TOLERANCE FOR FACTOR-VIII
    KREUZ, W
    BECKER, S
    LENZ, E
    MARTINEZSAGUER, I
    ESCURIOLAETTINGSHAUSEN, C
    FUNK, M
    EHRENFORTH, S
    AUERSWALD, G
    KORNHUBER, B
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1995, 21 (04): : 382 - 389
  • [33] IMPACT OF FACTOR-VIII DEFICIENCY ON CLOTTING FACTOR UTILIZATION IN THE UNITED-STATES
    ALEDORT, LM
    GOODNIGHT, SH
    RAO, AV
    SCHWARZ, J
    WHITEHURST, D
    SHAPIRO, SS
    RICERCA IN CLINICA E IN LABORATORIO, 1983, 13 (01): : 33 - 41
  • [34] THE INCIDENCE OF FACTOR-VIII INHIBITORS IN PATIENTS WITH HEMOPHILIA-A
    SCHWARZINGER, I
    LECHNER, K
    NIESSNER, H
    PABINGER, I
    HAEMOSTASIS, 1985, 15 (01) : 17 - 17
  • [35] CLINICAL PHARMACOKINETICS OF FACTOR-VIII IN PATIENTS WITH CLASSIC HEMOPHILIA
    MESSORI, A
    LONGO, G
    MATUCCI, M
    MORFINI, M
    FERRINI, PLR
    CLINICAL PHARMACOKINETICS, 1987, 13 (06) : 365 - 380
  • [36] RATE OF SYNTHESIS OF FACTOR-VIII AND DECAY OF FACTOR-VIII AND VON-WILLEBRAND-FACTOR (VWF) IN SEVERE VON-WILLEBRAND DISEASE (VWD)
    MENACHE, D
    ARONSON, DL
    DARR, F
    MONTGOMERY, RR
    BLOOD, 1994, 84 (10) : A238 - A238
  • [37] Pharmacokinetics (PK) of recombinant and plasma-derived factor VIII (FVIII) products in pediatric patients with severe hemophilia A
    Steele, M.
    Chan, A.
    Nagel, K.
    HAEMOPHILIA, 2012, 18 : 35 - 35
  • [38] COPPER-ATOM IDENTIFICATION IN THE DIFFERENT ACTIVE AND INACTIVE FORMS OF RECOMBINANT FACTOR-VIII-DELTA-II AND PLASMA-DERIVED FACTOR-VIII
    BIHOREAU, N
    RAMON, C
    PIN, S
    FONTAINEAUPART, MP
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1215 - 1215
  • [39] MAJOR REARRANGEMENT OF THE FACTOR-VIII GENE IN SEVERE HEMOPHILIA-A
    KARIYA, K
    SILVERMAN, L
    FRIEDMAN, K
    PERRY, T
    HIGHSMITH, W
    COOPER, H
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 201 - 201
  • [40] Factor VIII safety: plasma-derived versus recombinant products
    Gringeri, Alessandro
    BLOOD TRANSFUSION, 2011, 9 (04) : 366 - 370
12345